Outcomes of Perilla Seed Oil as an Additional Neuroprotective Therapy in Patients with Mild to Moderate Dementia: A Randomized Control Trial

Author(s): Chuntida Kamalashiran, Kusuma Sriyakul, Junya Pattaraarchachai, Sombat Muengtaweepongsa*.

Journal Name: Current Alzheimer Research

Volume 16 , Issue 2 , 2019

  Journal Home
Translate in Chinese
Submit Manuscript
Submit Proposal

Abstract:

Background: Dementia is a common medical disorder in the elderly. Oxidative stress plays a major role in the process of cognitive decline in dementia. Perilla seed oil demonstrates its neuroprotective effects via anti-oxidative mechanisms against dementia. We investigate neuroprotective effects of perilla seed oil as an additional treatment in patients with mild to moderate dementia.

Method: A double-blind, randomized-control trial (perilla seed oil versus placebo) in patients with mild to moderate dementia was conducted. Perilla seed oil or placebo was added on with standard treatment for six months. Cognitive function was compared at nine months after enrollment.

Result: 182 patients, with 94 in the experimental group and 88 in the placebo group, were able to complete the study. Cognitive function is not significantly different compared between groups. However, the total cholesterol and LDL cholesterol were significantly lower in the experimental group. Perilla seed oil had no adverse effect to kidney, liver, blood components or glucose metabolism.

Conclusion: Perilla seed oil as additional neuroprotective therapy in patients with mild to moderate dementia does not improve cognitive function. Perilla seed oil significantly reduced total cholesterol and LDL cholesterol. A clinical trial is needed to prove the benefit of cholesterol-lowering effects with perilla seed oil in human.

Keywords: Dementia perilla seed oil, oxidative stress, neuroprotective treatment, cognitive decline, neurodegenerative disorders, Parkinson's disease.

[1]
Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement 9: 63-75.e2. (2013).
[2]
World Health Organization. Dementia. 2017.
[3]
Elahi FM, Miller BL. A clinicopathological approach to the diagnosis of dementia. Nat Rev Neurol 13: 457-76. (2017).
[4]
Solfrizzi V, Frisardi V, Capurso C, D’Introno A, Colacicco AM, Vendemiale G, et al. Dietary fatty acids in dementia and predementia syndromes: epidemiological evidence and possible underlying mechanisms. Ageing Res Rev 9: 184-99. (2010).
[5]
Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. Global prevalence of dementia: a Delphi consensus study. Lancet (London, England) 366: 2112-27. (2005).
[6]
Sharp SI, Aarsland D, Day S, Sonnesyn H, Ballard C. Hypertension is a potential risk factor for vascular dementia: systematic review. Int J Geriatr Psychiatry 26: 661-9. (2011).
[7]
Alzheimer’s Association 2017 Alzheimer's disease facts and figures. Alzheimer's Dementia 13: 325-73 (2017).
[8]
Lasuka and Duangruedee. Dementia in Thailand : Current situation. Osaka University Knowledge Archive. 2014.
[9]
Shaji KS, Sivakumar PT, Rao GP, Paul N. Clinical practice guidelines for management of dementia. Indian J Psychiatry 60: S312-s28. (2018).
[10]
Szeto JYY, Lewis SJG. Current treatment options for Alzheimer’s disease and Parkinson’s disease dementia. Curr Neuropharmacol 14: 326-38. (2016).
[11]
Sies H. Oxidative stress: oxidants and antioxidants. Exp Physiol 82: 291-5. (1997).
[12]
Gsell W, Strein I, Riederer P. The neurochemistry of Alzheimer type, vascular type and mixed type dementias compared. J Neural Transm Suppl 47: 73-101. (1996).
[13]
Sayre LM, Perry G, Smith MA. Oxidative stress and neurotoxicity. Chem Res Toxicol 21: 172-88. (2008).
[14]
Cunnane S, Plourde M, Pifferi F, Bégin M, Féart C, Barberger-Gateau P. Fish, docosahexaenoic acid and Alzheimer’s disease. Prog Lipid Res 48: 239-56. (2009).
[15]
Nitta M, Lee JK, Ohnishi O. Asian Perilla crops and their weedy forms: their cultivation, utilization and genetic relationships. Econ Bot 57: 245-53. (2003).
[16]
Asif M. Health effects of omega-3,6,9 fatty acids: perilla frutescens is a good example of plant oils. Orient Pharm Exp Med 11: 51-9. (2011).
[17]
Bhardwaj K, Verma N, Trivedi RK, Bhardwaj S, Shukla N. Significance of ratio of Omega-3 and Omega-6 in human health with special reference to flaxseed oil. International J Biol Chem 10: 1-6. (2016).
[18]
Lee J, Park S, Lee J-Y, Yeo YK, Kim JS, Lim J. Improved spatial learning and memory by perilla diet is correlated with immunoreactivities to neurofilament and α-synuclein in hilus of dentate gyrus. Proteome Sci 10: 72. (2012).
[19]
Sun GY, Simonyi A, Fritsche KL, Chuang DY, Hannink M, Gu Z, et al. Docosahexaenoic acid (DHA): an essential nutrient and a nutraceutical for brain health and diseases. Prostaglandins Leukot Essent Fatty Acids 136: 3-13. (2018).
[20]
Crupi R, Marino A, Cuzzocrea S. n-3 fatty acids: role in neurogenesis and neuroplasticity. Curr Med Chem 20: 2953-63. (2013).
[21]
Kamalashiran C, Pattaraarchachai J, Muengtaweepongsa S. Feasibility and safety of perilla seed oil as an additional antioxidative therapy in patients with mild to moderate dementia. J Aging Res 2018: 5. (2018).
[22]
Eckert GP, Franke C, Noldner M, Rau O, Wurglics M, Schubert-Zsilavecz M, et al. Plant derived omega-3-fatty acids protect mitochondrial function in the brain. Pharmacol Res 61: 234-41. (2010).
[23]
Train The Brain Forum Committee TTBFC. Thai Mental State Examination (TMSE). 45: 16 (2017).
[24]
Tangwongchai S, Phanasathit M, Charernboon T, Akkayagorn L, Hemrungrojn S, Phanthumchinda K, et al. The validity of thai version of the montreal cognitive assessment (MoCA-T). Dement Neuropsychol 3: 172. (2009).
[25]
Di Santo SG, Prinelli F, Adorni F, Caltagirone C, Musicco M. A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer’s disease. J Alzheimers Dis 35: 349-61. (2013).
[26]
Longo FM, Massa SM. Neuroprotective strategies in Alzheimer’s disease. NeuroRx 1: 117-27. (2004).
[27]
Gamir-Morralla A, López-Menéndez C, Medina M, Iglesias T. Chapter 7 - A novel neuroprotection target with distinct regulation in stroke and Alzheimer’s disease. In: Gozes I, (ed.). Neuroprotection in Alzheimer's Disease. Academic Press, 2017, p. 123-47.
[28]
Cha Y, Jang JY, Ban YH, Guo H, Shin K, Kim TS, et al. Anti-atherosclerotic effects of perilla oil in rabbits fed a high-cholesterol diet. Lab Anim Res 32: 171-9. (2016).
[29]
Chen T, Yuan F, Wang H, Tian Y, He L, Shao Y, et al. Perilla oil supplementation ameliorates high-fat/high-cholesterol diet induced nonalcoholic fatty liver disease in rats via enhanced fecal cholesterol and bile acid excretion. BioMed Res Int 2016: 2384561. (2016).
[30]
Tian Y, Wang H, Yuan F, Li N, Huang Q, He L, et al. Perilla oil has similar protective effects of fish oil on high-fat diet-induced nonalcoholic fatty liver disease and gut dysbiosis. BioMed Res Internation 2016: 9462571. (2016).
[31]
McGuinness B, O’Hare J, Craig D, Bullock R, Malouf R, Passmore P. Statins for the treatment of dementia. Cochrane Database Syst Rev 4. (2010).


Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 16
ISSUE: 2
Year: 2019
Page: [146 - 155]
Pages: 10
DOI: 10.2174/1567205016666181212153720
Price: $58

Article Metrics

PDF: 22
HTML: 2
PRC: 1